文献速递重症综合管理与镇静镇痛儿科与产科急症

儿童ICU早期补充肠外营养的危害:PEPaNIC试验随机后治疗观察性研究

Effect of early supplemental parenteral nutrition in the paediatric ICU: a preplanned observational study of post-randomisation treatments in the PEPaNIC trial.
PubMed 文献 · Lancet Respir Med · 2017-05-15
一句话结论PEPaNIC试验的随机后观察性分析提示,重症患儿早期补充肠外营养的危害可能由氨基酸而非葡萄糖或脂质引起。

该研究是对PEPaNIC随机试验的随机后观察性分析,纳入1440例新生儿至17岁重症患儿,随机分为早期肠外营养(入PICU 24小时内,n=723)或晚期肠外营养(1周后,n=717)。将前7天葡萄糖、脂质、氨基酸剂量表示为指南参考剂量的百分比,用多因素Cox回归分析其与感染、活体脱机、活体出PICU的独立关联。结果显示氨基酸剂量增加与感染风险升高、活体脱机和出PICU可能性降低相关,且低剂量也有危害;葡萄糖在前3天增多与感染减少相关,脂质增多与第4-7天更早出PICU相关。作者认为早期补充肠外营养的危害可能由氨基酸而非葡萄糖或脂质解释。

要点

  • 重症患儿氨基酸剂量每增加10%,第1-5天新发感染风险升高(校正HR 1.043-1.134,p≤0.029),第3-7天活体脱机可能性降低(HR 0.950-0.975,p≤0.045),第1-7天活体出PICU可能性降低(HR 0.943-0.972,p≤0.030)。
  • 氨基酸相关危害在低剂量时也已显现。
  • 前3天葡萄糖剂量增多与感染减少独立相关(HR 0.870-0.913,p≤0.036)。
  • 第4-7天脂质剂量增多与更早活体出PICU独立相关(HR 1.027-1.050,p≤0.043)。
  • 作者认为,早期补充肠外营养的危害可能由氨基酸而非葡萄糖或脂质解释。

适用人群与场景

  • PEPaNIC随机试验纳入的新生儿至17岁重症患儿,收入PICU后随机接受早期或晚期补充肠外营养。
  • 随机后观察性分析纳入1440例患儿:早期肠外营养组723例,晚期肠外营养组717例。

处置流程与药物剂量

  • 早期肠外营养组在入PICU 24小时内开始补充肠外营养;晚期肠外营养组在1周后、肠内营养不足时开始补充肠外营养。
  • 前7天葡萄糖、脂质、氨基酸剂量以已发表年龄体重临床指南参考剂量的百分比表示。

研究设计与关键结果

  • 研究类型为PEPaNIC随机试验的随机后观察性研究,纳入1440例新生儿至17岁重症患儿,随机分为早期肠外营养组(n=723)和晚期肠外营养组(n=717)。
  • 氨基酸剂量每增加10%,第1-5天新发感染风险升高(校正HR 1.043-1.134,p≤0.029),第3-7天活体脱机可能性降低(HR 0.950-0.975,p≤0.045),第1-7天活体出PICU可能性降低(HR 0.943-0.972,p≤0.030)。
  • 前3天葡萄糖剂量增多与感染减少独立相关(HR 0.870-0.913,p≤0.036)。
  • 第4-7天脂质剂量增多与更早活体出PICU独立相关(HR 1.027-1.050,p≤0.043)。
  • 氨基酸相关危害在低剂量时也已显现。

证据类型、等级与局限

  • 证据类型:随机对照试验的随机后观察性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,早期补充肠外营养的危害可能由氨基酸而非葡萄糖或脂质解释。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Large randomised controlled trials have shown that early supplemental parenteral nutrition in patients admitted to adult and paediatric intensive care units (PICUs) is harmful. Overdosing of energy with too little protein was suggested as a potential reason for this. This study analysed which macronutrient was associated with harm caused by early supplemental parenteral nutrition in the Paediatric Early versus Late Parenteral Nutrition In Critical Illness (PEPaNIC) randomised trial.

METHODS: Patients in the initial randomised controlled trial were randomly assigned to receive suppplemental parenteral nutrition (PN) within 24 h of PICU admission (early PN) or to receive such PN after 1 week (late PN) when enteral nutrition was insufficient. In this post-randomisation, observational study, doses of glucose, lipids, and aminoacids administered during the first 7 days of PICU stay were expressed as % of reference doses from published clinical guidelines for age and weight. Independent associations between average macronutrient doses up to each of the first 7 days and likelihood of acquiring an infection in the PICU, of earlier live weaning from mechanical ventilation, and of earlier live PICU discharge were investigated using multivariable Cox proportional hazard analyses. The three macronutrients were included in the analysis simultaneously and baseline risk factors were adjusted for.

FINDINGS: From June 18, 2012, to July 27, 2015, 7519 children aged between newborn and 17 years were assessed for eligibility. 6079 patients were excluded, and 1440 children were randomly assigned to receive either early PN (n=723) or late PN (n=717). With increasing doses of aminoacids, the likelihood of acquiring a new infection was higher (adjusted hazard ratios [HRs] per 10% increase between 1·043-1·134 for days 1-5, p≤0·029), while the likelihood of earlier live weaning from mechanical ventilation was lower (HRs 0·950-0·975 days 3-7, p≤0·045), and the likelihood of earlier live PICU discharge was lower (HRs 0·943-0·972 days 1-7, p≤0·030). By contrast, more glucose during the first 3 days of PICU stay was independently associated with fewer infections (HRs 0·870-0·913, p≤0·036), whereas more lipids was independently associated with earlier PICU discharge (HRs 1·027-1·050, p≤0·043 days 4-7). Risk of harm with aminoacids was also shown for low doses.

INTERPRETATION: These associations suggest that early administration of aminoacids, but not glucose or lipids, could explain harm caused by early supplemental parenteral nutrition in critically ill children.

FUNDING: Flemish Agency for Innovation through Science and Technology; UZLeuven Clinical Research Fund; Research Foundation Flanders; Methusalem Programme Flemish Government; European Research Council; Fonds-NutsOhra; Erasmus-MC Research Grant; Erasmus Trustfonds.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Vanhorebeek I, Verbruggen S, Casaer MP, et al. Effect of early supplemental parenteral nutrition in the paediatric ICU: a preplanned observational study of post-randomisation treatments in the PEPaNIC trial. Lancet Respir Med. 2017. PMID: 28522351. doi:10.1016/S2213-2600(17)30186-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。